| 000 | 01048 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514050407.0 | ||
| 264 | 0 | _c20030312 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1354-3784 | ||
| 024 | 7 |
_a10.1517/13543784.11.10.1387 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHovinga, Collin A | |
| 245 | 0 | 0 |
_aNovel anticonvulsant medications in development. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cOct 2002 |
||
| 300 |
_a1387-406 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfusion Pumps, Implantable _xtrends |
| 650 | 0 | 4 |
_aIon Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xinstrumentation |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 11 _gno. 10 _gp. 1387-406 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.11.10.1387 _zAvailable from publisher's website |
| 999 |
_c12196779 _d12196779 |
||